Associate Director/Senior Clinical Trial Manager
TLDR
Manage clinical studies from setup through final report, coordinating clinical teams, CROs, vendors, and investigative sites.
Scholar Rock is delivering muscle-targeted breakthroughs to transform the treatment of spinal muscular atrophy (SMA) and other rare neuromuscular diseases where muscle atrophy remains a critical unmet need.
As a global leader in myostatin biology, a field focused on proteins that regulate muscle mass, the biopharmaceutical company is named for the visual resemblance of a scholar rock to protein structures. Our commitment to unlock fundamentally different treatment approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. Scholar Rock works every day to create new possibilities for patients through its highly innovative anti-myostatin program, including opportunities in additional rare neuromuscular diseases. Learn more about our neuromuscular franchise at ScholarRock.com and follow @ScholarRock on X and on LinkedIn.
Summary of Position:
The Senior Clinical Trial Manager is responsible for all operational aspects of a clinical study from setup through final report, with support from Clinical Operations Leadership. Depending on the size of the study, the Clinical Trial Manager may coordinate the activities of several other clinical team members (e.g. Clinical Research Associates, Data Managers), as well as several external clinical vendors and/ or consultants. The Senior Clinical Trial Manager may also assume the role of the in-house Lead Clinical Research Associate for a study, as needed.
Position Responsibilities
Candidate Requirements
Scholar Rock is an Equal Opportunity Employer. We celebrate diversity and are committed to creating an inclusive environment for all employees.
Scholar Rock is a biopharmaceutical company dedicated to discovering and developing innovative therapies for patients with serious diseases that lack effective treatment options. By specializing in the biology of the transforming growth factor beta (TGFβ) superfamily of proteins, we are positioned to create groundbreaking treatments that address significant unmet medical needs across multiple conditions, including neuromuscular diseases and cancer.
- Founded
- Founded 2012
- Employees
- 51-200 employees
- Industry
- Biotechnology
- Total raised
- $100M raised